Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Washington University School of Medicine
Tempus AI
Cedars-Sinai Medical Center
Stanford University
Actuate Therapeutics Inc.
National Cancer Institute (NCI)
RefleXion Medical
Celgene
InSightec
InSightec
InSightec
Imunon
Centre Hospitalier Universitaire de Besancon
Stanford University
InSightec
The University of Texas Health Science Center at San Antonio